Key facts
- Albert Health’s last known valuation is $4.6M (Jun 2022).
- It has raised $3.0M; the latest was Accelerator/Incubator in Jan 2019.
- Notable investors include Techstars, Turkey Development Fund, Maxis Private Equity Portfolio Management, Türk Telekom Ventures, Eksim Venture — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Albert Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Albert Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Albert Health
Developer of an evidence-based multi-chronic disease management platform designed to help patients take the right dose of medicine at the right time. The company's platform leverages artificial intelligence to provide medication reminders and records, track health measurements, and warn about adverse drug events, enabling patients to manage medications while sharing data with doctors and letting families monitor treatment.
- Sector
- Healthcare
- HQ
- Istanbul, Turkey
- Founded
- 2018
- Employees
- 24
- Website
- albert.health/
- Ownership
- Privately Held (backing)
Albert Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Albert Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Albert Health in its N-PORT filings yet. We sweep new filings monthly.